Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable?
For ondansetron, dexamethasone, and droperidol (when used for prophylaxis), each is estimated to reduce risk of postoperative nausea and/or vomiting (PONV) by approximately 25%. Current consensus guidelines denote that patients with 0–1 risk factors still have a 10–20% risk of encountering PONV, but...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2007-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2007.131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558813244293120 |
|---|---|
| author | Susan J. Skledar Brian A. Williams Manuel C. Vallejo Patricia L. Dalby Jonathan H. Waters Ronald Glick Michael L. Kentor |
| author_facet | Susan J. Skledar Brian A. Williams Manuel C. Vallejo Patricia L. Dalby Jonathan H. Waters Ronald Glick Michael L. Kentor |
| author_sort | Susan J. Skledar |
| collection | DOAJ |
| description | For ondansetron, dexamethasone, and droperidol (when used for prophylaxis), each is estimated to reduce risk of postoperative nausea and/or vomiting (PONV) by approximately 25%. Current consensus guidelines denote that patients with 0–1 risk factors still have a 10–20% risk of encountering PONV, but do not yet advocate routine prophylaxis for all patients with 10–20% risk. In ambulatory surgery, however, multimodal prophylaxis has gained favor, and our previously published experience with routine prophylaxis has yielded PONV rates below 10%. We now propose a “zero-tolerance” antiemetic algorithm for outpatients that involves routine prophylaxis by first avoiding volatile agents and opioids to the extent possible, using locoregional anesthesia, multimodal analgesia, and low doses of three nonsedating off-patent antiemetics. Routine oral administration (immediately on arrival to the ambulatory surgery suite) of perphenazine 8 mg (antidopaminergic) or cyclizine 50 mg (antihistamine), is followed by dexamethasone 4 mg i.v. after anesthesia induction (dexamethasone is avoided in diabetic patients). At the end of surgery, ondansetron (4 mg i.v., now off-patent) is added. Rescue therapy consists of avoiding unnecessary repeat doses of drugs acting by the same mechanism: haloperidol 2 mg i.v. (antidopaminergic) is prescribed for patients pretreated with cyclizine or promethazine 6.25 mg i.v. (antihistamine) for patients having been pretreated with perphenazine. If available, a consultation for therapeutic acupuncture procedure is ordered. Our approach toward “zero tolerance” of PONV emphasizes liberal identification of and prophylaxis against common risks. |
| format | Article |
| id | doaj-art-912ac7caed8c424fa091202b6c72736f |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2007-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-912ac7caed8c424fa091202b6c72736f2025-02-03T01:31:31ZengWileyThe Scientific World Journal1537-744X2007-01-01795997710.1100/tsw.2007.131Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable?Susan J. Skledar0Brian A. Williams1Manuel C. Vallejo2Patricia L. Dalby3Jonathan H. Waters4Ronald Glick5Michael L. Kentor6University of Pittsburgh School of Pharmacy and Director - Drug Use and Disease State Management Program, University of Pittsburgh Medical Center, Pittsburgh, PA, USADepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USADepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USADepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USADepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USADepartments of Psychiatry, Physical Medicine and Rehabilitation, and Family Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USADepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAFor ondansetron, dexamethasone, and droperidol (when used for prophylaxis), each is estimated to reduce risk of postoperative nausea and/or vomiting (PONV) by approximately 25%. Current consensus guidelines denote that patients with 0–1 risk factors still have a 10–20% risk of encountering PONV, but do not yet advocate routine prophylaxis for all patients with 10–20% risk. In ambulatory surgery, however, multimodal prophylaxis has gained favor, and our previously published experience with routine prophylaxis has yielded PONV rates below 10%. We now propose a “zero-tolerance” antiemetic algorithm for outpatients that involves routine prophylaxis by first avoiding volatile agents and opioids to the extent possible, using locoregional anesthesia, multimodal analgesia, and low doses of three nonsedating off-patent antiemetics. Routine oral administration (immediately on arrival to the ambulatory surgery suite) of perphenazine 8 mg (antidopaminergic) or cyclizine 50 mg (antihistamine), is followed by dexamethasone 4 mg i.v. after anesthesia induction (dexamethasone is avoided in diabetic patients). At the end of surgery, ondansetron (4 mg i.v., now off-patent) is added. Rescue therapy consists of avoiding unnecessary repeat doses of drugs acting by the same mechanism: haloperidol 2 mg i.v. (antidopaminergic) is prescribed for patients pretreated with cyclizine or promethazine 6.25 mg i.v. (antihistamine) for patients having been pretreated with perphenazine. If available, a consultation for therapeutic acupuncture procedure is ordered. Our approach toward “zero tolerance” of PONV emphasizes liberal identification of and prophylaxis against common risks.http://dx.doi.org/10.1100/tsw.2007.131 |
| spellingShingle | Susan J. Skledar Brian A. Williams Manuel C. Vallejo Patricia L. Dalby Jonathan H. Waters Ronald Glick Michael L. Kentor Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? The Scientific World Journal |
| title | Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? |
| title_full | Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? |
| title_fullStr | Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? |
| title_full_unstemmed | Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? |
| title_short | Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? |
| title_sort | eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating off patent antiemetics is zero tolerance achievable |
| url | http://dx.doi.org/10.1100/tsw.2007.131 |
| work_keys_str_mv | AT susanjskledar eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT brianawilliams eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT manuelcvallejo eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT patricialdalby eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT jonathanhwaters eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT ronaldglick eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable AT michaellkentor eliminatingpostoperativenauseaandvomitinginoutpatientsurgerywithmultimodalstrategiesincludinglowdosesofnonsedatingoffpatentantiemeticsiszerotoleranceachievable |